ZIOPHARM ONCOLOGY INC - FORM 10-K - EX-23.1 - February 28, 2011

Attached files

file filename
10-K - ZIOPHARM ONCOLOGY INCv212557_10k.htm
EX-32.2 - ZIOPHARM ONCOLOGY INCv212557_ex32-2.htm
EX-23.2 - ZIOPHARM ONCOLOGY INCv212557_ex23-2.htm
EX-31.1 - ZIOPHARM ONCOLOGY INCv212557_ex31-1.htm
EX-31.2 - ZIOPHARM ONCOLOGY INCv212557_ex31-2.htm
EX-10.1 - ZIOPHARM ONCOLOGY INCv212557_ex10-1.htm
EX-32.1 - ZIOPHARM ONCOLOGY INCv212557_ex32-1.htm
EX-10.21 - ZIOPHARM ONCOLOGY INCv212557_ex10-21.htm
EX-10.24 - ZIOPHARM ONCOLOGY INCv212557_ex10-24.htm
                          Exhibit 23.1
  
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
 We consent to the incorporation by reference in the Registration Statements on Forms S-8 (File Nos. 333-129884, 333-134280, 333-142701, 333-160496 and 333-167925) and Forms S-3 (File Nos. 333-129680, 333-134279, 333-141014, 333-161453, 333-162160, 333-163517 and 333-166444) of ZIOPHARM Oncology, Inc. of our report dated February 28, 2011 relating to our audit of the financial statements and the effectiveness of internal control over financial reporting, which appears in this Annual Report on Form 10-K of ZIOPHARM Oncology, Inc. for the year ended December 31, 2010.
 
/s/McGladrey & Pullen, LLP
 
Boston, Massachusetts
February 28, 2011
 
 
 
 

ZIOPHARM ONCOLOGY INC Reports